IP Group cash realisations in 2019 increased to more than £75m across multiple portfolio holdings IP Group plc (LSE: IPO) (“IP Group” or “the Group”), the developer of intellectual property-based businesses, notes that its portfolio company Oxford Nanopore Technologies Limited (“Oxford Nanopore”) has announced that it has raised £29.3 million of new capital and facilitated […]
REDWOOD CITY, Calif. — Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces a license agreement to provide Roche with Codexis’ EvoT4TM DNA ligase high-performance molecular diagnostic enzyme. This enzyme was developed using Codexis’ proprietary CodeEvolver® protein engineering platform and is expected to be incorporated into Roche’s next generation sequencing (NGS) library preparation kits and other […]
SAN DIEGO, California SGI-DNA, Inc., a company dedicated to developing transformative synthetic genomics technologies and revolutionary DBA data storage solutions, today announced the appointment of Brian Donnelly to the newly created position of Chief Commercial Officer. Mr. Donnelly is a seasoned commercial and operational leader with expertise in developing markets and launching disruptive technologies in […]
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that the International Trade Commission (ITC) affirmed the Administrative Law Judge’s finding that 10X Genomics infringed three of Bio-Rad’s patents. The Commission also issued a Limited Exclusion Order and Cease and Desist Order against 10X […]
DUBAI, UAE, December, 2019 – Euformatics, a world-leader in NGS data quality control applications and variant interpretation solutions, has appointed Dubai-headquartered Alliance Global (AGBL) as the exclusive distributor for its bioinformatics software in the Middle East, Asia and Africa. “Euformatics is delighted to be working with Alliance Global as our exclusive distributor in the region to […]
LAUSANNE, Switzerland – Nagi Bioscience SA, a Swiss life-science-tech company developing a revolutionary technology for the in vitro testing of drugs and chemicals, announced today the closing of a CHF 1.8 million Seed financing round. Investors in the round include the leading Swiss venture capital platform investiere, Zürcher Kantonalbank, NEST pension fund and private investors from […]
ANN ARBOR, Mich. — Akadeum Life Sciences, Inc. announced an initial close of its Series A financing. The company is pursuing additional investment before final close during Q1 2020. These funds will enable Akadeum to focus its commercial adoption on how to solve longstanding problems in sample preparation. The investment includes several Michigan-based angel groups in addition […]
Saphyr helps provide a better understanding of ALS, Alzheimer’s disease and Parkinson’s disease SAN DIEGO — Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that Mayo Clinic has adopted the Saphyr system. A team led by Dr. Mark Ebbert brought the Saphyr system in-house after determining that Bionano’s technology can provide a deeper understanding of the […]
Getinge announces today an agreement to acquire 100% of the shares in Applikon Biotechnology B.V. from Applikon Biotechnology Holding B.V.. Applikon Biotechnology B.V. is a leading company in the fast growing area of advanced bioreactor systems for biopharmaceutical production and research, with an annual net sales of approximately SEK 450 M. “Applikon Biotechnology has a […]
Gives scientists a new view into natural cell activity, accelerating drug development MilliporeSigma, a leader in genome editing, today announced that it has signed a license agreement providing Promega Corp., a global life science manufacturer based in Madison, Wisconsin, access to MilliporeSigma’s foundational CRISPR intellectual property. Promega will use MilliporeSigma’s CRISPR genome-editing technology to create research products […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
